Diabetech - Diabetes Tech, Research, and News

We dive into growing concerns around reliability issues with the Dexcom G7. After posting a video online that sparked nearly 1,000 comments from users reporting sensor failures, it became clear that this wasn’t an isolated problem. To explore what’s going on, I’m joined by two experts in the diabetes space: Kamil of the Nerdabetic YouTube channel, and Dr. David Ahn, a practicing endocrinologist. We discuss the recent FDA warning le...

Today we explore the evolution of continuous glucose monitors (CGMs) — from the first professional CGM in 1999 to the advanced tech driving today’s AID systems, and how these devices changed patient lives along the way. Dr. Grazia Aleppo, a leading endocrinologist and early CGM believer, joins to discuss early CGM innovations, the challenges of adoption, and pivotal research that expanded global access. Plus, we look ahead to what ...

I sit down with someone who wore the first consumer insulin pump—the AutoSyringe We dive into what diabetes treatment was like at the time, how the early pump worked, and how decades of evolving tech have shaped her journey and inspired her to educate others. It’s a powerful look at how far we’ve come in diabetes innovation. 

Learn about Omnipod 5 (today's sponsor)*

T1D Exchange Registry Sign up  (US residents only)

Watch Thi...

I sit down with veteran game developer and T1D dad Sam Glassenberg, creator of Level One—a new smartphone game designed to teach newly diagnosed patients and their families the fundamentals of T1D management. From insulin-to-carb ratios to the impact of exercise and fat on blood sugar, Level One turns complex concepts into fun, interactive levels. With early praise from endocrinologists and patients alike, this could be the educati...

Today’s CGMs measure glucose through fluid under the skin—but what if we could measure it directly from the blood? Today we explore Glucotrack, an implantable device that could become the world’s first continuous blood glucose monitor (CBGM). I’m joined by Glucotrack's CEO and Chief Scientific Officer to discuss the major advantages this device could offer over today’s CGMs. We cover how the sensor works, how it's implanted, and it...

I share my experience after nearly three months using the Tandem Mobi, the smallest tubed hybrid closed-loop pump currently available in the U.S. I’m joined by diabetes educator and fellow Mobi user David Mina to dive deep into how Tandem’s Control-IQ algorithm works — including updates with Control-IQ+ — and what to consider before switching from other pumps like the Omnipod. We also discuss David’s journey to becoming an educator...

We take a journey back to the roots of the #WeAreNotWaiting movement—before CGM follower apps—when a group of determined parents and developers built their own tools to monitor glucose remotely. I sit down with James Wedding, founder of the Nightscout Foundation, to talk about the early days of Nightscout, how it transformed life for families managing diabetes, and the powerful role the open-source community played in pushing the i...

In this episode, we dive into the major shift happening in the U.S. diabetes tech industry: insulin pumps are moving from Durable Medical Equipment (DME) to pharmacy benefits, offering easier access, lower costs, and more flexibility for users. I’m joined by Jeff DelVerne, author of The Healthcare Economy Substack and Director of Payer Relations at Beta Bionics, to break down what this transition means for people with diabetes. We ...

In this episode, I sit down with Amy Tenderich, one of the first diabetes bloggers, whose open letter to Steve Jobs called for better, more user-friendly diabetes technology. That bold move launched her deeper into the world of diabetes advocacy and innovation, eventually leading her to create D-Data Exchange—a powerful forum where industry leaders, regulators, and patient voices come together to push diabetes tech forward. We talk...

Can we stop type 1 diabetes before it starts? I’m joined by Sam Reich, CEO of SAB Bio, and Dr. Mike Haller, a leading T1D researcher, to explore an innovative new therapy called SAB-142. Unlike traditional thymoglobulin, which is derived from rabbits, SAB’s therapy uses a fully human version produced by genetically engineered cows—potentially eliminating harmful side effects like serum sickness. We unpack how this treatment could d...

We explore Android APS (AAPS)—a powerful open-source automated insulin delivery system that runs on Android phones and uses the advanced o-ref algorithm. AAPS offers features like Dynamic ISF (Insulin Sensitivity Factor), Dynamic CR (Carb Ratio), Unannounced Meal detection (UAM), and Super Micro Boluses (SMBs), making it one of the most customizable diabetes tech options out there. Our guest, Austin Sympson, a competitive cyclist w...

The twiist insulin pump from Sequel Med Tech is releasing in Q2 of 2025. is bringing a new spin to tubed pump therapy. I met with Sequel's CEO to dive into twiist's launch CGM integration with Libre 3 Plus to its advanced occlusion technology designed for more reliable insulin delivery. We also break down how patients will access twiist through pharmacy benefit managers, a shift that could make the pump more accessible. For more co...

Endocrinologist David Ahn and I break down the biggest diabetes tech announcements from the ATTD conference in Amsterdam! We dive into the highly anticipated Twiist pump, the newly unveiled and more powerful Kaleido 2, Tandem’s game-changing Control IQ+ algorithm update, Dexcom’s 15-day sensor, and more. This was a HUGE week for diabetes innovation—What are you most excited for? Let us know on Youtube!

Watch This Episode On Youtu...

The ADA’s Standards of Care shape diabetes treatment, technology access, and insurance coverage worldwide. In this episode, we break down the latest updates, including a major new recommendation that all people with type 2 diabetes—regardless of insulin use—have access to CGM. We also explore the ADA’s stance on emerging diabetes technologies and why these guidelines are considered the “gold standard” for diabetes management. Joini...

DIY Loop is one of the most powerful and customizable automated insulin delivery systems for type 1 diabetes, offering features like overrides, retroactive carb adjustments, and glycemic index logging. In this episode, fellow Loop user Jake Giles joins me to share our experiences getting started, the support (or lack thereof) from doctors, and a deep dive into key features like carb logging by glycemic index, creating custom overri...

Sernova’s innovative Cell Pouch implants insulin-producing cells, and early trials have helped some people achieve full insulin independence for years. But challenges like immunosuppressants and scalability remain. In this episode, I’m joined by Jonathan Rigby, CEO of Sernova and a fellow T1D, to discuss how this technology works, the life-changing results from clinical trials, and the next steps in diabetes cure research. We explo...

In the aftermath of the devastating January 2025 Los Angeles fires, a grassroots group of volunteers, led by You’re Just My Type, sprang into action to deliver life-saving medical supplies to people with type 1 diabetes. Liz Van Horhis, who had only planned to visit L.A. for a dog-sitting trip, found herself at the heart of the relief effort. She shares how a simple favor turned into a mission to get critical medications to those i...

For decades, people with type 1 diabetes have heard that a cure is just “5-10 years away” – yet here we are, still waiting. Many have grown skeptical, but after this conversation, you might just walk away with hope! Journalist and fellow T1D Ginger Vieira joins me to break down the latest breakthroughs in diabetes cure research. From companies that have already cured people to game-changing innovations that eliminate the need for i...

2025 is set to bring major advancements in diabetes technology, from AI-driven CGMs to new insulin pumps like Medtronic’s upcoming 8-series and patch pump, and the Tidepool Loop-based twiist pump. I spoke with Gary Scheiner, a CDCES and author of Think Like a Pancreas, to break down what these innovations mean for diabetes management.

Learn about Omnipod 5 (today's sponsor)*

T1D Exchang...